Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.

Johannsson G, Bidlingmaier M, Biller BMK, Boguszewski M, Casanueva FF, Chanson P, Clayton PE, Choong CS, Clemmons D, Dattani M, Frystyk J, Ho K, Hoffman AR, Horikawa R, Juul A, Kopchick JJ, Luo X, Neggers S, Netchine I, Olsson DS, Radovick S, Rosenfeld R, Ross RJ, Schilbach K, Solberg P, Strasburger C, Trainer P, Yuen KCJ, Wickstrom K, Jorgensen JOL; Growth Hormone Research Society.

Endocr Connect. 2018 Mar;7(3):R126-R134. doi: 10.1530/EC-18-0047. Epub 2018 Feb 26. Review.

2.

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.

Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF, Chanson P, Chatelain P, Choong CS, Clemmons DR, Cohen LE, Cohen P, Frystyk J, Grimberg A, Hasegawa Y, Haymond MW, Ho K, Hoffman AR, Holly JM, Horikawa R, Höybye C, Jorgensen JO, Johannsson G, Juul A, Katznelson L, Kopchick JJ, Lee KO, Lee KW, Luo X, Melmed S, Miller BS, Misra M, Popovic V, Rosenfeld RG, Ross J, Ross RJ, Saenger P, Strasburger CJ, Thorner MO, Werner H, Yuen K.

Eur J Endocrinol. 2016 Jun;174(6):C1-8. doi: 10.1530/EJE-16-0111. Epub 2016 Mar 23.

3.

Biomarkers of GH action in children and adults.

Schilbach K, Olsson DS, Boguszewski MCS, Bidlingmaier M, Johannsson G, Jørgensen JL.

Growth Horm IGF Res. 2018 Jun;40:1-8. doi: 10.1016/j.ghir.2018.03.005. Epub 2018 Mar 20. Review.

PMID:
29601998
5.

[Lowered ghrelin levels in acromegaly—normalization after treatment].

Kozakowski J, Rabijewski M, Zgliczyński W.

Endokrynol Pol. 2005 Nov-Dec;56(6):862-70. Polish.

PMID:
16821203
6.

Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?

Costa AC, Rossi A, Martinelli CE Jr, Machado HR, Moreira AC.

J Clin Endocrinol Metab. 2002 Jul;87(7):3142-7.

PMID:
12107214
7.
8.

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.

Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM Jr, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV.

J Clin Psychiatry. 2010 Aug;71(8):e1-e21. doi: 10.4088/JCP.10cs06070blu.

PMID:
20797373
9.

Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.

Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM; 2007 ISS Consensus Workshop participants.

J Clin Endocrinol Metab. 2008 Nov;93(11):4210-7. doi: 10.1210/jc.2008-0509. Epub 2008 Sep 9.

PMID:
18782877
10.

Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.

Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Florimonte L, Salvatore M, Lombardi G.

J Clin Endocrinol Metab. 1999 Jan;84(1):17-23.

PMID:
9920056
11.

Diagnosis of acromegaly: state of the art.

Kannan S, Kennedy L.

Expert Opin Med Diagn. 2013 Sep;7(5):443-53. doi: 10.1517/17530059.2013.820181. Epub 2013 Jul 31. Review.

PMID:
23971897
12.

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.

Kaltsas GA, Isidori AM, Florakis D, Trainer PJ, Camacho-Hubner C, Afshar F, Sabin I, Jenkins JP, Chew SL, Monson JP, Besser GM, Grossman AB.

J Clin Endocrinol Metab. 2001 Apr;86(4):1645-52.

PMID:
11297598
13.

Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.

Skjaerbaek C, Frystyk J, Kaal A, Laursen T, Møller J, Weeke J, Jørgensen JO, Sandahl Christiansen J, Orskov H.

Clin Endocrinol (Oxf). 2000 Jan;52(1):25-33.

PMID:
10651750
14.

Effects of a growth hormone receptor antagonist on bone markers in acromegaly.

Fairfield WP, Sesmilo G, Katznelson L, Pulaski K, Freda PU, Stavrou S, Kleinberg D, Klibanski A.

Clin Endocrinol (Oxf). 2002 Sep;57(3):385-90.

PMID:
12201832
15.

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report.

Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM Jr, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV.

J Clin Psychiatry. 2010 Aug;71(8):1040-6. doi: 10.4088/JCP.10cs06070ablu. Epub 2010 Jul 13.

PMID:
20673551
16.

Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.

Miller KK, Wexler T, Fazeli P, Gunnell L, Graham GJ, Beauregard C, Hemphill L, Nachtigall L, Loeffler J, Swearingen B, Biller BM, Klibanski A.

J Clin Endocrinol Metab. 2010 Feb;95(2):567-77. doi: 10.1210/jc.2009-1611. Epub 2010 Jan 8.

17.

Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.

Dobrashian RD, O'Halloran DJ, Hunt A, Beardwell CG, Shalet SM.

Clin Endocrinol (Oxf). 1993 Jun;38(6):589-93.

PMID:
8334745
18.

The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.

Jayasena CN, Comninos AN, Clarke H, Donaldson M, Meeran K, Dhillo WS.

Clin Endocrinol (Oxf). 2011 Aug;75(2):220-5. doi: 10.1111/j.1365-2265.2011.04019.x.

PMID:
21521288
19.

A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.

Holdaway IM, Bolland MJ, Gamble GD.

Eur J Endocrinol. 2008 Aug;159(2):89-95. doi: 10.1530/EJE-08-0267. Epub 2008 Jun 4.

PMID:
18524797
20.

Supplemental Content

Support Center